We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Publish open access with Taylor & Francis Toxicology and Pharmacology

Explore our portfolio of fully open access journals in Toxicology and Pharmacology

Taylor & Francis Group is a leading publisher of Toxicology and Pharmacology research worldwide. We offer an outstanding portfolio of fully open access Toxicology and Pharmacology journals. In 2019, we published 560 articles across the portfolio, and are set to publish even more in 2020. Have a browse through these titles below, and find the perfect home for your next research article.


2018 Impact Factor 5.333

OncoImmunology is a peer-reviewed, open access journal which focuses specifically on tumor immunology. OncoImmunology serves as a platform for groundbreaking research that's making an impact.

Indexed in PubMed, Scopus, and 7 other databases.

Find out more

Journal of Enzyme Inhibition and Medicinal Chemistry

2018 Impact Factor of 4.027

An international and interdisciplinary open access journal, publishing new knowledge and findings on enzyme inhibitors and inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents. 

Indexed in Medline, BIOSIS, Scopus, the DOAJ + over 10 others.

Find out more

Drug Delivery

2018 Impact Factor 3.829

Drug Delivery is a peer-reviewed, open access journal which covers the research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. 

Indexed in PubMed, Scopus, and 12 other databases.

Find out more

Toxicology Communications

Toxicology Communications publishes case reports and rapid communications in toxicology, of interest to clinical and research toxicologists, pharmacologists and forensic toxicologists.

The journal encourages veterinary case reports that can demonstrate implications for human health.

Find out more

Pharmaceutical Biology

2018 Impact Factor of 2.492

Pharmaceutical Biology is an open access, peer reviewed journal, publishing high-level research on natural medicines, as well as biologically active natural products and their derivatives. 

Indexed in PubMed, BIOSIS Previews, Scopus, the DOAJ + over 30 others.

Find out more

Journal of Immunotoxicology

2018 Impact Factor of 1.734

The Journal of Immunotoxicology is an open access, peer-reviewed journal that publishes research from many subdisciplines including molecular, developmental, pulmonary, regulatory, nutritional , mechanistic, wildlife and environmental immunotoxicology, immunology, and toxicology.

Indexed in PubMed, Scopus, BIOBASE, EMBASE, the DOAJ, +5 more.

Find out more

Why Publish Open Access?

Publishing open access can increase the visibility of your research, helping you make an impact beyond your field.
Find out more

F1000 Research

F1000Research is an open research publishing platform for scientists and researchers offering rapid publication of articles and other research outputs with transparent peer-review and the inclusion of all source data.
Go to F1000Research

Questions about the publishing process?

Visit our dedicated and ever-expanding site for authors, Author Services, to find out more about how to get published and your publishing options.

Follow @tandfmedicine for up-to-date research, insights, and resources from the Taylor & Francis medicine and health portfolio